Hans Edgar Bishop, CEO and President at Juno Therapeutics, Inc. (JUNO), sold 91,500 shares at $45.73 ($4.2M) on 2015-12-15, disclosed to the SEC on 2015-12-17.
Scheduled sale ($4.2M) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.77 | 30,841 | $1.4M | 33.0% |
| 2 | $45.73 | 29,404 | $1.3M | 32.1% |
| 3 | $46.64 | 31,255 | $1.5M | 34.8% |
| Total | $45.72 avg | 91,500 | $4.2M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-21 | $4.9M | — | Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |